| Lindsey Vallejo, OD | |
|
816 S James Campbell Boulevard, Columbia, TN 38401 | |
| (931) 540-0700 | |
| Not Available |
| Full Name | Lindsey Vallejo |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 816 S James Campbell Boulevard, Columbia, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356861025 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 3391 (Tennessee) | Primary |
| Provider Name | Lorena R Cron |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1346216173 PECOS PAC ID: 7618084112 Enrollment ID: I20101116000170 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the second quarter ended June 30, 2010.
bitop AG, a biotech company specializing in the development of Ectoin®-containing medical devices, reports that Ectoin allergy nasal spray has been shown to significantly reduce symptoms of acute allergic rhinitis in a two-week observational, randomized, comparative crossover study with 50 patients suffering from acute allergic rhinitis. Based on this study, bitop performed a clinical trial on eyes drops and nasal spray in humans using an environmental exposure chamber (EEC) model.
PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced that the United States Securities and Exchange Commission (SEC) has notified the Company that it has completed a two and half year investigation of the Company related to revenue recognition, earnings, company operations and related party transactions and does not intend to recommend any enforcement action by the Commission. The investigation, which is now closed, was originally initiated as an informal investigation in 2006 and became formal in March 2007.
Results from a large study show that diastolic hypotension is a consistent predictor of admission to hospital in all children with asthma.
Delphi Genetics SA has announced today a broad licensing agreement with a subsidiary of Merck & Co., Inc., known as MSD outside the United States and Canada, for the use of the StabyExpress technology, which allows high yield, cost effective protein expression without the use of antibiotics.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lindsey Vallejo, OD 1547 River Rd, Chapel Hill, TN 37034-2118 Ph: () - | Lindsey Vallejo, OD 816 S James Campbell Boulevard, Columbia, TN 38401 Ph: (931) 540-0700 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the second quarter ended June 30, 2010.
bitop AG, a biotech company specializing in the development of Ectoin®-containing medical devices, reports that Ectoin allergy nasal spray has been shown to significantly reduce symptoms of acute allergic rhinitis in a two-week observational, randomized, comparative crossover study with 50 patients suffering from acute allergic rhinitis. Based on this study, bitop performed a clinical trial on eyes drops and nasal spray in humans using an environmental exposure chamber (EEC) model.
PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced that the United States Securities and Exchange Commission (SEC) has notified the Company that it has completed a two and half year investigation of the Company related to revenue recognition, earnings, company operations and related party transactions and does not intend to recommend any enforcement action by the Commission. The investigation, which is now closed, was originally initiated as an informal investigation in 2006 and became formal in March 2007.
Results from a large study show that diastolic hypotension is a consistent predictor of admission to hospital in all children with asthma.
Delphi Genetics SA has announced today a broad licensing agreement with a subsidiary of Merck & Co., Inc., known as MSD outside the United States and Canada, for the use of the StabyExpress technology, which allows high yield, cost effective protein expression without the use of antibiotics.
› Verified 5 days ago
Shelby Haviland, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1301 Trotwood Ave, Columbia, TN 38401 Phone: 931-388-9041 | |
Myeyedr. Optometrist Medicare: Medicare Enrolled Practice Location: 840 Hatcher Ln, Columbia, TN 38401 Phone: 931-381-4911 Fax: 931-381-0966 | |
Dr. Thomas Daniel Snead Jr., O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1940 Shady Brook Street, Suite E, Columbia, TN 38401 Phone: 931-380-2660 Fax: 931-380-1004 | |
Dr. Kurt A. Jeter, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1301 Trotwood Ave, Columbia, TN 38401 Phone: 931-380-3036 | |
Dr. Stanley M Dickerson, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 840 Hatcher Ln, Columbia, TN 38401 Phone: 931-381-4911 Fax: 931-381-0966 | |
Mallard Eye Care Columbia Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2200 Brookmeade Dr, Columbia, TN 38401 Phone: 931-381-3900 |